Piperaquine

Jump to navigation Jump to search
Piperaquine
File:Piperaquine.png
Identifiers
CAS Number
PubChem CID
UNII
ChEMBL
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC29H32Cl2N6
Molar mass535.51
3D model (JSmol)
 ☒N☑Y (what is this?)  (verify)

WikiDoc Resources for Piperaquine

Articles

Most recent articles on Piperaquine

Most cited articles on Piperaquine

Review articles on Piperaquine

Articles on Piperaquine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Piperaquine

Images of Piperaquine

Photos of Piperaquine

Podcasts & MP3s on Piperaquine

Videos on Piperaquine

Evidence Based Medicine

Cochrane Collaboration on Piperaquine

Bandolier on Piperaquine

TRIP on Piperaquine

Clinical Trials

Ongoing Trials on Piperaquine at Clinical Trials.gov

Trial results on Piperaquine

Clinical Trials on Piperaquine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Piperaquine

NICE Guidance on Piperaquine

NHS PRODIGY Guidance

FDA on Piperaquine

CDC on Piperaquine

Books

Books on Piperaquine

News

Piperaquine in the news

Be alerted to news on Piperaquine

News trends on Piperaquine

Commentary

Blogs on Piperaquine

Definitions

Definitions of Piperaquine

Patient Resources / Community

Patient resources on Piperaquine

Discussion groups on Piperaquine

Patient Handouts on Piperaquine

Directions to Hospitals Treating Piperaquine

Risk calculators and risk factors for Piperaquine

Healthcare Provider Resources

Symptoms of Piperaquine

Causes & Risk Factors for Piperaquine

Diagnostic studies for Piperaquine

Treatment of Piperaquine

Continuing Medical Education (CME)

CME Programs on Piperaquine

International

Piperaquine en Espanol

Piperaquine en Francais

Business

Piperaquine in the Marketplace

Patents on Piperaquine

Experimental / Informatics

List of terms related to Piperaquine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Piperaquine is an antimalarial drug, a bisquinoline first synthesised in the 1960s, and used extensively in China and Indochina as prophylaxis and treatment during the next 20 years. Usage declined in the 1980s as piperaquine-resistant strains of P. falciparum arose and artemisinin-based antimalarials became available. However, Chinese scientists have been studying whether piperaquine can still be used therapeutically in combination with artemisinin.[1]

Piperaquine is characterized by slow absorption and a long biological half-life,[2] making it a good partner drug with artemisinin derivatives which are fast acting but have a short biological half-life.[3]

The fixed-dose combination dihydroartemisinin-piperaquine (Eurartesim) was submitted for approval to the European Medicines Agency in 2009.[4]

References

  1. Davis TM, Hung TY, Sim IK, Karunajeewa HA, Ilett KF (2005). "Piperaquine: a resurgent antimalarial drug". Drugs. 65 (1): 75–87. PMID 15610051.
  2. D'alessandro U. (2009). "Progress in the development of piperaquine combinations for the treatment of malaria". Curr Opin Infect Dis. 22 (6): 588–92. PMID 19773652.
  3. http://apps.who.int/prequal/info_applicants/Guidelines/Nonclinical_Overview_Artemisinin-Derivatives.pdf"
  4. Medicines for Malaria. "Registration". Retrieved 2010-06-20.


Template:Antiinfective-drug-stub